Rockwell Medical Reports Q1 2025 Financial Results

Rockwell Medical ( (RMTI) ) has released its Q1 earnings. Here is a breakdown of the information Rockwell Medical presented to its investors.

Rockwell Medical, Inc. is a healthcare company specializing in the development, manufacturing, and distribution of hemodialysis products for dialysis providers globally. The company is recognized for its high-quality products and customer-centric approach.

In its first quarter of 2025, Rockwell Medical reported net sales of $18.9 million, marking a 17% decrease from the previous year, attributed to the loss of its largest customer. Despite this, the company maintained a gross profit of $3.0 million, consistent with the same period in 2024.

Key financial highlights include a gross margin increase to 16% from 14% the previous year, and a net loss of $1.5 million, showing a 12% improvement from 2024. The company’s cash reserves decreased to $17.3 million, influenced by the timing of payments and seasonal expenses. Rockwell Medical also expanded its product portfolio by adding a single-use bicarbonate cartridge through a new distribution agreement.

Looking ahead, Rockwell Medical maintains its annual guidance for 2025, projecting net sales between $65.0 million and $70.0 million, with a gross margin of 16% to 18%. The company remains focused on cost management and operational efficiency to sustain its market position.